Yu Lin

839 total citations
23 papers, 648 citations indexed

About

Yu Lin is a scholar working on Molecular Biology, Epidemiology and Immunology. According to data from OpenAlex, Yu Lin has authored 23 papers receiving a total of 648 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 7 papers in Epidemiology and 4 papers in Immunology. Recurrent topics in Yu Lin's work include Glycosylation and Glycoproteins Research (11 papers), Liver Disease Diagnosis and Treatment (6 papers) and Liver physiology and pathology (3 papers). Yu Lin is often cited by papers focused on Glycosylation and Glycoproteins Research (11 papers), Liver Disease Diagnosis and Treatment (6 papers) and Liver physiology and pathology (3 papers). Yu Lin collaborates with scholars based in United States, China and Japan. Yu Lin's co-authors include Matthew R. Pratt, David M. Lubman, Ralf Langen, Don B. Arnold, Balyn W. Zaro, Mark R. Ambroso, Nicholas P. Marotta, Tharindumala Abeywardana, Neehar D. Parikh and Amit G. Singal and has published in prestigious journals such as PLoS ONE, Biochemistry and Nature Chemistry.

In The Last Decade

Yu Lin

22 papers receiving 645 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yu Lin United States 12 454 152 137 86 76 23 648
E. V. Dyatlovitskaya Russia 15 535 1.2× 56 0.4× 110 0.8× 20 0.2× 63 0.8× 31 688
Jinjun Gao China 14 862 1.9× 135 0.9× 134 1.0× 6 0.1× 63 0.8× 22 1.2k
Shu‐Ping Wang China 17 484 1.1× 101 0.7× 51 0.4× 11 0.1× 20 0.3× 36 919
Claudia Ruiz United States 20 616 1.4× 399 2.6× 30 0.2× 28 0.3× 54 0.7× 36 1.0k
S.L. Gande Germany 15 475 1.0× 74 0.5× 41 0.3× 6 0.1× 68 0.9× 30 718
Joana Soares Portugal 16 456 1.0× 122 0.8× 28 0.2× 24 0.3× 27 0.4× 21 713
Alban Girault France 16 648 1.4× 55 0.4× 65 0.5× 6 0.1× 42 0.6× 28 949
Haixia Zou China 9 382 0.8× 99 0.7× 46 0.3× 30 0.3× 43 0.6× 11 782
Jianke Li China 13 313 0.7× 85 0.6× 23 0.2× 26 0.3× 20 0.3× 39 679
Guang‐Yaw Liu Taiwan 20 616 1.4× 20 0.1× 105 0.8× 19 0.2× 48 0.6× 50 936

Countries citing papers authored by Yu Lin

Since Specialization
Citations

This map shows the geographic impact of Yu Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Lin more than expected).

Fields of papers citing papers by Yu Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Lin. The network helps show where Yu Lin may publish in the future.

Co-authorship network of co-authors of Yu Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Yu Lin. A scholar is included among the top collaborators of Yu Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu Lin. Yu Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Meng, Shan Fu, Yu Lin, et al.. (2024). C/EBPα-p30 confers AML cell susceptibility to the terminal unfolded protein response and resistance to Venetoclax by activating DDIT3 transcription. Journal of Experimental & Clinical Cancer Research. 43(1). 79–79. 4 indexed citations
2.
Johnson, Zachary, Xiguang Xu, Yu Lin, & Hehuang Xie. (2023). Dynamics of RNA m5C modification during brain development. Genomics. 115(3). 110604–110604. 6 indexed citations
3.
Tan, Yifei, Jianhui Zhu, Cristian D. Gutierrez Reyes, et al.. (2023). Discovery of Core-Fucosylated Glycopeptides as Diagnostic Biomarkers for Early HCC in Patients with NASH Cirrhosis Using LC-HCD-PRM-MS/MS. ACS Omega. 8(13). 12467–12480. 10 indexed citations
4.
Lin, Yu & David M. Lubman. (2023). The role of N-glycosylation in cancer. Acta Pharmaceutica Sinica B. 14(3). 1098–1110. 54 indexed citations
5.
Lin, Yu, Manting Huang, Jiazhong Cai, et al.. (2023). Overview of distinct 5-methylcytosine profiles of messenger RNA in normal and knock-down NSUN2 colorectal cancer cells. Frontiers in Genetics. 14. 1121063–1121063. 9 indexed citations
6.
Mechref, Yehia, Wenjing Peng, Sakshi Gautam, et al.. (2022). Mass spectrometry based biomarkers for early detection of HCC using a glycoproteomic approach. Advances in cancer research. 157. 23–56. 5 indexed citations
7.
Lin, Yu, Jie Zhang, Ana Huerta, et al.. (2022). A Fucosylated Glycopeptide as a Candidate Biomarker for Early Diagnosis of NASH Hepatocellular Carcinoma Using a Stepped HCD Method and PRM Evaluation. Frontiers in Oncology. 12. 818001–818001. 11 indexed citations
8.
Lin, Yu, et al.. (2022). Large Scale Screening and Quantitative Analysis of Site-Specific N-Glycopeptides from Human Serum in Early Alzheimer's Disease Using LC-HCD-PRM-MS.. PubMed. 15(5). 1 indexed citations
10.
Li, Tianxu, Xinyu Zhai, Wenjie Wang, et al.. (2021). Regulation of MDA5-dependent anti-Tembusu virus innate immune responses by LGP2 in ducks. Veterinary Microbiology. 263. 109281–109281. 4 indexed citations
11.
Lin, Yu, Jianhui Zhu, Zhijing Tan, et al.. (2021). A Panel of Glycopeptides as Candidate Biomarkers for Early Diagnosis of NASH Hepatocellular Carcinoma Using a Stepped HCD Method and PRM Evaluation. Journal of Proteome Research. 20(6). 3278–3289. 29 indexed citations
12.
Zhu, Jianhui, Junfeng Huang, Zhengwei Chen, et al.. (2020). Glycopeptide Biomarkers in Serum Haptoglobin for Hepatocellular Carcinoma Detection in Patients with Nonalcoholic Steatohepatitis. Journal of Proteome Research. 19(8). 3452–3466. 44 indexed citations
13.
Lin, Yu, Christopher J. Halbrook, Kelly N. Chuh, et al.. (2019). Inhibiting the Hexosamine Biosynthetic Pathway Lowers O-GlcNAcylation Levels and Sensitizes Cancer to Environmental Stress. Biochemistry. 59(34). 3169–3179. 28 indexed citations
15.
Marotta, Nicholas P., Yu Lin, Mark R. Ambroso, et al.. (2015). O-GlcNAc modification blocks the aggregation and toxicity of the protein α-synuclein associated with Parkinson's disease. Nature Chemistry. 7(11). 913–920. 226 indexed citations
16.
Lin, Yu, et al.. (2015). Gallic Acid Induces Necroptosis via TNF–α Signaling Pathway in Activated Hepatic Stellate Cells. PLoS ONE. 10(3). e0120713–e0120713. 49 indexed citations
18.
Lin, Yu & Matthew R. Pratt. (2014). A Dual Small‐Molecule Rheostat for Precise Control of Protein Concentration in Mammalian Cells. ChemBioChem. 15(6). 805–809. 10 indexed citations
19.
Abeywardana, Tharindumala, Yu Lin, Ruth Rott, Simone Engelender, & Matthew R. Pratt. (2013). Site-Specific Differences in Proteasome-Dependent Degradation of Monoubiquitinated α-Synuclein. Chemistry & Biology. 20(10). 1207–1213. 41 indexed citations
20.
Jiang, Xiaoyun, et al.. (2009). [Intensive reading of steroid-sensitive, relapsing/steroid-dependent nephrotic syndrome: evidence-based guidelines on diagnosis and treatment of childhood common renal diseases (I)].. PubMed. 47(3). 171–2. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026